Uncover the evolving landscape of the pharmaceutical industry in IQVIA's white paper, "Safety & Regulatory Predictions for 2024". From interviews with our safety and regulatory experts, learn their informed predictions about the impact of cutting-edge technologies like artificial intelligence (AI) and machine learning on drug development and pharmacovigilance in the upcoming years. The white paper offers a deep-dive into the anticipated challenges and regulatory shifts and how Generative Artificial Intelligence (GenAI) is set to play a transformative role. Furthermore, it underscores the criticality of harmonizing safety services with technological advancements for overall operational efficacy and patient safety. The white paper also outlines the prospective application of AI-powered chatbots in the industry.